Pervasive Developmental Disorder - Not Otherwise Specified

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2019-04-24
Clinical Trial Update: Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine [Phase 2]
Clinical trial update on a Phase 2 withdrawal study of memantine in pediatric patients with autism spectrum disorders after prior memantine …